TOKYO (Nikkei)--A Japanese plan to host the International Linear Collider is already under threat. The problem is a matter of funding.
OSAKA (Nikkei)--Dainippon Sumitomo Pharma Co. (4506) plans to develop technologies for mass-producing cell sheets made from induced pluripotent stem cells for treating a retinal disease, hoping to seek approval for commercialization as early as 2018.
SILICON VALLEY (Nikkei)--Apple Inc.'s latest iPad models unveiled Tuesday are full of technologies that started in Japan. Many are the intellectual properties of Japanese manufacturers, but many have also become the sole property of the U.S. tech giant as part of its strategy to stay on the cutting edge.
TOKYO (Nikkei)--Companies are developing new, less-expensive manufacturing methods so that they do not have to pass rises in raw materials prices onto their products.
TOKYO (Nikkei)--The world's first major hydrogen power plant project is under way in Japan, as use of the basic and abundant chemical element gains momentum as a major power source.